Zobrazeno 1 - 10
of 111
pro vyhledávání: '"S. Echechipía"'
Autor:
E Arroabarren, M. T. Lizaso, Arkaitz Galbete, José María Olaguibel, Ana I. Tabar, S. Echechipía
Publikováno v:
Journal of investigational allergologyclinical immunology. 29(2)
Autor:
Blanca E. García, Jorge M. Núñez-Córdoba, Marta Ferrer, Marina Sabaté Brescó, Carmen Diaz Donado, José Manuel Zubeldia, Dolores Quiñones, Pere Gaig, Maria L. Baeza, Ana Sala-Cunill, Julián Azofra, Moises Labrador-Horrillo, Ana Beristain, Gabriel Gastaminza, S. Echechipía
Publikováno v:
The journal of allergy and clinical immunology. In practice. 7(5)
Background Cholinergic urticaria (UCOL) is a highly disabling inducible urticaria triggered by an increase in core body temperature. Objective To explore the safety and efficacy of omalizumab in controlling UCOL. Methods We conducted a multicenter ra
Autor:
Ana I. Tabar, Marta Anda, M. T. Lizaso, E. M. Lasa, Blanca E. García, B. Gómez, S. Echechipía, M. J. Alvarez
Publikováno v:
Annals of Allergy, Asthma & Immunology. 107:35-41
Background Component-resolved diagnostics (CRD) has recently been introduced into clinical allergology. Objective The aim of this study was to assess the contribution that this new diagnostic technique makes to conventional diagnosis in patients with
Autor:
Javier Figueroa, Cesarea Sanchez, Fernando de la Torre, Susana Lizarza, Carmen Vidal, Mª Teresa Lizaso, Agustin Orovitg, Alejandro Joral, Ana I. Tabar, Virginia Rodríguez, S. Echechipía, Jose Antonio Navarro, Margarita Armisén
Publikováno v:
Current Drug Delivery. 8:152-158
Background: Once the optimal dose is reached, subcutaneous immunotherapy [SCIT] with mite extract is capable of reducing symptoms and the need for rescue medication. Objective: To assess the capacity of a subcutaneous extract of mites [D. pteronyssin
Autor:
M. T. Lizaso, Blanca E. García, S. Echechipía, Marta Anda, Maria J. Alvarez-Puebla, Antonio Rodriguez, Esozia Arroabarren, José María Olaguibel, Ana I. Tabar, Maria Teresa Aldunate, B. Gómez, Sara Garrido
Publikováno v:
Clinical and Translational Allergy
Methods Retrospective review of patients attending the Emergency Department (2009-2013) for a NSAID induced anaphylaxis and with a tryptase determination. Patients were split into 3 groups according to the allergy workup Results Selective reactions (
Autor:
S. Echechipía, Fernando Marcotegui, M. T. Lizaso, Santiago Martín, B. Gómez, Blanca E. García, José María Olaguibel, Maria Teresa Aldunate, Ana I. Tabar
Publikováno v:
Journal of Allergy and Clinical Immunology. 116:109-118
Background The conventional schedule for subcutaneous immunotherapy with allergen extracts, although efficacious and safe, is slow during the dose-increase phase. Objective We sought to compare the efficacy and safety of subcutaneous immunotherapy wi
Autor:
S. Echechipía, José María Olaguibel, R. Sánchez-Monge, Gabriel Salcedo, Araceli Díaz-Perales, Manuel Lombardero, Domingo Barber, Blanca E. García, Ana I. Tabar
Publikováno v:
Clinical Experimental Allergy. 34:291-295
Summary Background Several lipid-transfer proteins (LTPs) have been identified as important food allergens, especially in fruits of the Rosaceae family. The major peach (Prunus persica) allergen has been identified, sequenced and designated Pru p 3.
Autor:
José María Olaguibel, Rico P, S. Echechipía, S. Martin, Blanca E. García, M. J. Alvarez, Ana I. Tabar
Publikováno v:
Clinical & Experimental Allergy. 32:1574-1582
Summary Background Allergen vaccination is effective in mite-allergic asthma. Liposomes are immunological adjuvants that can act as allergen carriers. Objective To evaluate the immunological and functional effects of a liposome-entrapped D. pteronyss
Autor:
M. T. Lizaso, Ana I. Tabar, José María Olaguibel, B. Gómez, B.E. García, E. Arroabarren, M. Anda, S. Echechipía
Publikováno v:
Allergologia et Immunopathologia. 30:163-170
Latex allergy currently constitutes a serious problem because of the severity of its symptoms and the at-risk groups it affects. Since complete avoidance of this substance is practically impossible, in the last few years intense efforts have been mad
Autor:
Ana I. Tabar, Maria J. Alvarez-Puebla, S. Echechipía, Koldo Cambra, Blanca E. García, Esozia Arroabarren
Publikováno v:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 26(1)
Background Subcutaneous immunotherapy (SCIT) discontinuation data in children remain scarce. Objective We sought for differences in the clinical efficacy of 3 vs. 5 yr of SCIT in children with dust mite respiratory allergy. Methods We performed a 5-y